Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

36.29
-1.7400-4.58%
Post-market: 36.290.00000.00%16:38 EDT
Volume:671.95K
Turnover:24.65M
Market Cap:1.95B
PE:-18.03
High:38.39
Open:37.72
Low:36.18
Close:38.03
52wk High:39.15
52wk Low:6.42
Shares:53.87M
Float Shares:17.22M
Volume Ratio:0.65
T/O Rate:3.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0125
EPS(LYR):-2.0125
ROE:-39.83%
ROA:-25.68%
PB:7.54
PE(LYR):-18.03

Loading ...

Tyra Biosciences Advances BEACH301 Dose Escalation

TIPRANKS
·
Feb 05

Tyra Bioscience (TYRA) Gets a Buy from Oppenheimer

TIPRANKS
·
Feb 03

Tyra Biosciences Is Maintained at Buy by Jefferies

Dow Jones
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

Tyra Biosciences Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Tyra Biosciences initiated with an Overweight at Barclays

TIPRANKS
·
Jan 28

Tyra Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jan 23

Tyra Biosciences price target raised to $42 from $33 at Piper Sandler

TIPRANKS
·
Jan 23

Tyra Biosciences Inc : Piper Sandler Raises Target Price to $42 From $33

THOMSON REUTERS
·
Jan 23

How Investors May Respond To Tyra Biosciences (TYRA) Strengthening Its Leadership Team And Regulatory Focus

Simply Wall St.
·
Jan 22

Tyra Biosciences Chief Discovery Officer Daniel Bensen Reports Sale of Common Shares

Reuters
·
Jan 21

Tyra Biosciences (TYRA) Is Up 9.4% After New COO Hire And 52-Week High Has The Bull Case Changed?

Simply Wall St.
·
Jan 11

Tyra Biosciences (TYRA): Assessing Valuation After New Leadership Hires and Biotechnology Index Inclusion

Simply Wall St.
·
Dec 26, 2025

Tyra Biosciences Director Robert J. More Reports Sale of Common Shares

Reuters
·
Dec 20, 2025

Tyra Biosciences Chief Discovery Officer Daniel Bensen Reports Sale of Common Shares

Reuters
·
Dec 17, 2025

Tyra Biosciences Is Maintained at Outperform by Wedbush

Dow Jones
·
Dec 16, 2025

Wedbush Raises Price Target on Tyra Bioscience to $37 From $30, Adds Stock to Best Ideas List, Keeps Outperform Rating

MT Newswires Live
·
Dec 16, 2025

Tyra Biosciences Inc : Wedbush Raises Target Price to $37 From $30

THOMSON REUTERS
·
Dec 16, 2025

Assessing Tyra Biosciences (TYRA) Valuation Following Key Executive Hires to Support Advancing Clinical Pipeline

Simply Wall St.
·
Dec 15, 2025

How Investors Are Reacting To Tyra Biosciences (TYRA) Bolstering Its Regulatory And Oncology Leadership

Simply Wall St.
·
Dec 10, 2025